Prophase Labs Inc PRPH.OQ PRPH.O is expected to show a rise in quarterly revenue when it reports results on November 7 (estimated) for the period ending September 30 2024
The New York City-based company is expected to report a 185.1% increase in revenue to $23.85 million from $8.37 million a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Prophase Labs Inc is for earnings of 4 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Prophase Labs Inc is $18.50, above its last closing price of $2.08.
This summary was machine generated November 6 at 14:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)